Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption|
|Citation:||Journal of Orthopaedic Research, 1999; 17(5):686-694|
|Neale, Susan D. ; Sabokbar, Afsaneh ; Howie, Donald W. ; Murray, David W. ; Athanasou, Nicholas A.|
|Abstract:||Periprosthetic bone loss is an important contributory factor for aseptic loosening of total joint replacements. It has recently been shown that osteoclast precursor cells are present in the wear particle-associated macrophage infiltrate found in the membrane surrounding loose implants and that these cells are capable of differentiating into osteoclastic bone-resorbing cells. Long-term co-culture of arthroplasty-derived macrophages and the rat osteoblast-like cell line, UMR-106, in the presence of 1,25(OH)2D3 results in the formation of numerous multinucleated cells that are positive for tartrate-resistant acid phosphatase and vitronectin receptor and capable of extensive lacunar bone resorption. The aim of this study was to determine the effect of cytokines/growth factors, known to be present in the arthroplasty membrane, on this process of osteoclast differentiation. During osteoclast formation, increased levels of macrophage colony-stimulating factor, interleukin-6, and to a lesser extent, interleukin-1beta, but not tumour necrosis factor alpha, were detected in the co-culture supernatants. Addition of neutralising antibodies to human interleukin-1beta or tumour necrosis factor alpha to the co-culture system did not inhibit osteoclast formation. In contrast, co-cultures to which neutralising antibodies to human macrophage colony-stimulating factor or interleukin-6 were added contained fewer cells positive for tartrate-resistant acid phosphatase and vitronectin receptor and formed significantly fewer resorption pits. Time-course studies showed that macrophage colony-stimulating factor and interleukin-6 increase osteoclast formation mainly in the early stages of osteoclast differentiation. These results indicate that the release of macrophage colony-stimulating factor and interleukin-6 by activated cells in the arthroplasty membrane is likely to contribute to pathological bone resorption associated with aseptic loosening by stimulating differentiation of mononuclear phagocyte osteoclast precursors into mature bone-resorbing cells.|
|Keywords:||Femur; Acetabulum; Periosteum; Cells, Cultured; Macrophages; Osteoclasts; Humans; Bone Resorption; Tumor Necrosis Factor-alpha; Macrophage Colony-Stimulating Factor; Antigens, CD14; Macrophage-1 Antigen; Interleukin-1; Interleukin-6; Antibodies; Arthroplasty, Replacement, Hip; Cell Differentiation; Aged; Aged, 80 and over; Middle Aged; Female; Male|
|Rights:||Copyright © 1999 Orthopaedic Research Society|
|Appears in Collections:||Orthopaedics and Trauma publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.